Literature DB >> 12559510

Neurophysiological evidence for long-term repair of MS lesions: implications for axon protection.

Steve J Jones1, Adriana Brusa.   

Abstract

After recovery from the acute stage of optic neuritis, a marked prolongation in the latencies of visual evoked potentials (VEPs) is typically observed. We have conducted three studies (one cross-sectional, two prospective), aimed at elucidating the progressive shortening of VEP latency, which frequently ensues over the following months or years. This has been shown to be a progressive process and a prevalent tendency in the patient population, proceeding for more than 2 years in spite of the fact that very little functional improvement in vision occurs after the first few months. We argue that the underlying process of repair is most likely to involve remyelination of demyelinated optic nerve axons. Rather than restoration of visual function (which may be virtually complete after as short a period as 3 months), the main importance of the long-term myelin repair process may consist in protecting demyelinated axons from subsequent, permanent degeneration. In the VEPs of the acutely unaffected fellow eyes followed up over 3 years, we observed an asymptomatic deterioration, possibly due to insidious processes of demyelination and/or axonal degeneration. Even in the relapsing/remitting stage of MS, therefore, there is electrophysiological evidence for involvement of clinically asymptomatic axons, which, in the later stages, may be manifested as progressive functional deterioration.

Entities:  

Mesh:

Year:  2003        PMID: 12559510     DOI: 10.1016/s0022-510x(02)00428-8

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  19 in total

1.  Reproducibility of multifocal VEP latency using different stimulus presentations.

Authors:  Prema Sriram; Alexander Klistorner; Hemamalini Arvind; Stuart L Graham
Journal:  Doc Ophthalmol       Date:  2012-06-06       Impact factor: 2.379

2.  Correlation between full-field and multifocal VEPs in optic neuritis.

Authors:  Alexander Klistorner; Clare Fraser; Raymond Garrick; Stuart Graham; Hemamalini Arvind
Journal:  Doc Ophthalmol       Date:  2007-08-07       Impact factor: 2.379

3.  New developments in the treatment of optic neuritis.

Authors:  Thomas M Jenkins; Ahmed T Toosy
Journal:  Eye Brain       Date:  2010-06-17

4.  Diffusion tensor imaging of the optic nerve in subacute anterior ischemic optic neuropathy at 3T.

Authors:  M-Y Wang; P-H Qi; D-P Shi
Journal:  AJNR Am J Neuroradiol       Date:  2011-06-23       Impact factor: 3.825

5.  Evoked potentials as a biomarker of remyelination.

Authors:  Moones Heidari; Abigail B Radcliff; Gillian J McLellan; James N Ver Hoeve; Kore Chan; Julie A Kiland; Nicholas S Keuler; Benjamin K August; Dylan Sebo; Aaron S Field; Ian D Duncan
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-16       Impact factor: 11.205

6.  Retinal ganglion cell and axonal loss in optic neuritis: risk factors and visual functions.

Authors:  T H Lee; Y S Ji; S W Park; H Heo
Journal:  Eye (Lond)       Date:  2016-11-18       Impact factor: 3.775

7.  Comparison of multifocal visual evoked potential, standard automated perimetry and optical coherence tomography in assessing visual pathway in multiple sclerosis patients.

Authors:  Michal Laron; Han Cheng; Bin Zhang; Jade S Schiffman; Rosa A Tang; Laura J Frishman
Journal:  Mult Scler       Date:  2010-03-05       Impact factor: 6.312

8.  Dynamic visual tests to identify and quantify visual damage and repair following demyelination in optic neuritis patients.

Authors:  Noa Raz; Michal Hallak; Tamir Ben-Hur; Netta Levin
Journal:  J Vis Exp       Date:  2014-04-14       Impact factor: 1.355

9.  Reproducibility of multifocal visual evoked potential and traditional visual evoked potential in normal and multiple sclerosis eyes.

Authors:  Divya Narayanan; Han Cheng; Rosa A Tang; Laura J Frishman
Journal:  Doc Ophthalmol       Date:  2014-10-29       Impact factor: 2.379

Review 10.  Visual electrophysiology in the clinical evaluation of optic neuritis, chiasmal tumours, achiasmia, and ocular albinism: an overview.

Authors:  Jelka Brecelj
Journal:  Doc Ophthalmol       Date:  2014-06-25       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.